MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$385M
AUM Growth
-$36.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
43
New
Increased
Reduced
Closed

Top Buys

1
+$21.3M
2
+$8.2M
3
+$4.01M
4
VERV
Verve Therapeutics
VERV
+$3.35M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$2.87M

Top Sells

1
+$18.4M
2
+$9.36M
3
+$7.63M
4
YMAB
Y-mAbs Therapeutics
YMAB
+$6.4M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$5.22M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.32M 0.6%
319,671
27
$2.2M 0.57%
195,942
+2,616
28
$2.1M 0.54%
+80,000
29
$1.45M 0.38%
+40,667
30
$601K 0.16%
2,377,031
31
$462K 0.12%
53,993
32
$261K 0.07%
144,888
-95,000
33
$242K 0.06%
230,500
-430,644
34
– –
-304,027
35
– –
-97,322
36
– –
-918,310
37
– –
-270,388
38
– –
-443,702
39
– –
-334,384
40
– –
-412,363
41
– –
-605,663
42
– –
-193,205
43
– –
-405,700
1
2